WellGen’s own Dr. Shiming Li presented research about the analytical method for measuring polyphenols and the polyphenol content in ready-to-drink tea beverages at the American Chemical Society (ACS) meeting that began August 22 in Boston. The research conducted at WellGen analyzed the content of polyphenols in 49 commercially available beverages, specifically bottled ready-to-drink tea, as part of the development process for medical food products for diabetes. We wanted to better understand the commercial products that are alleged to be sources of antioxidants and specifically polyphenols as we develop our own products. Bottled tea is a $2.2 billion consumer market yet the tea polyphenol content in the bottled tea beverages is low relative to the expected consumer health benefits.
While we believe that this research helps strengthen our own product offerings, we hope that it will encourage the use of rigorous analytical methods for the measurement and reporting of nutrients with health benefits.
03/03/10
Study Results Revealed
01/08/10
“About Harvest” Podcast Features WellGen
12/07/09
WellGen, Inc. and RFI Ingredients to Collaborate on Therapeutic Nutrition Opportunities
11/18/09
WellGen Recognized as Nutraceutical “Innovator” by Global Business Insights
04/07/09
Dr. Roddy Carter Named President and Chief Executive Officer
09/02/08
Robert J. Bertoldi Appointed Interim Chief Executive Officer of WellGen
02/12/08
WellGen Names Robert M. Hellauer as Chief Financial Officer
12/18/07
WellGen Names Nancy E. Rawson, Ph.D., Chief Scientific Officer
08/24/10
Health Benefits from Tea: Perception vs. Reality
06/01/10
The Scientific & Medical Significance of Inflammation
03/17/10
Modulating Inflammation Provides Clinical Benefits for Diabetes
03/03/10
Study Results Revealed
10/01/09
Diabetes Connections
12/18/07
WellGen Names Nancy E. Rawson, Ph.D., Chief Scientific Officer